Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis

被引:0
|
作者
Poynton, Edward [1 ,2 ]
Chernucha, Emily [3 ]
Day, James [2 ]
Prodger, Catherine [4 ]
Hopkins, David [5 ]
Rakesh, Pallav [5 ,6 ]
O'Neill, Tess [7 ]
Thakrar, Nisha [2 ]
Akarca, Ayse [8 ]
Jamal, Esraa [1 ]
Ali, Ayesha [9 ]
Kirkwood, Amy A. [10 ]
Pomplun, Sabine [8 ]
Marafioti, Teresa [8 ]
Calaminici, Maria
Greaves, Paul [11 ]
Chaganti, Sridhar [6 ]
Mckay, Pam
Smith, Jeffery [12 ]
Eyre, Toby A.
Martinez-Calle, Nicolas [3 ]
Cwynarski, Kate [2 ]
Fox, Christopher P. [13 ]
Okosun, Jessica
机构
[1] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England
[2] Univ Coll London Hosp, Dept Clin Haematol, London, England
[3] Nottingham Univ Hosp NHS Trust, Nottingham, England
[4] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England
[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[6] Univ Hosp Birmingham NHS Fdn Trust, Ctr Clin Haematol, Birmingham, W Midlands, England
[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haemato Oncol, London, England
[8] Univ Coll London Hosp, Dept Histopathol, London, England
[9] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[10] UCL, Canc Res UK, London, England
[11] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Haematol, London, England
[12] Liverpool Univ Hosp, Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[13] Univ Nottingham, Sch Med, Nottingham, England
关键词
PCNSL; primary CNS Lymphoma; double expressor; MYC; BCL2;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ABCL-184
引用
收藏
页码:S423 / S424
页数:2
相关论文
共 50 条
  • [41] MYC/BCL2 double-expression vs. cell-of-origin classification in diffuse large B-cell lymphoma: do we need to know both?
    Sohani, Aliyah R.
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 509 - 511
  • [42] BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial
    Petrella, T.
    Copie-Bergman, C.
    Briere, J.
    Delarue, R.
    Jardin, F.
    Ruminy, P.
    Thieblemont, C.
    Figeac, M.
    Canioni, D.
    Feugier, P.
    Fabiani, B.
    Leroy, K.
    Parrens, M.
    Andre, M.
    Haioun, C.
    Salles, G. A.
    Gaulard, P.
    Tilly, H.
    Jais, J. P.
    Molina, T. J.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1042 - 1049
  • [43] Lymphoma-like double-hit genetic abnormalities (MYC/IGH and IGH/BCL2) in a case of non-secretory multiple myeloma
    Kaya, Erin A.
    Baughn, Linda B.
    Pham, Truc
    Ketterling, Rhett P.
    Kumar, Shaji K.
    Jevremovic, Dragan
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 243 - 246
  • [44] Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level
    Warnnissorn, Naree
    Kanitsap, Nonglak
    Niparuck, Pimjai
    Boonsakan, Paisarn
    Kulalert, Prapasri
    Limvorapitak, Wasithep
    Bhoopat, Lantarima
    Saengboon, Supawee
    Suriyonplengsaeng, Chinnawut
    Chantrathammachart, Pichika
    Puavilai, Teeraya
    Chuncharunee, Suporn
    BLOOD RESEARCH, 2024, 59 (01)
  • [45] Educational Case: Gastric High-Grade B-Cell Lymphoma With MYC and BCL2 Gene Rearrangement (Double-Hit Lymphoma)
    Betts, Elham Vali
    Rashidi, Hooman H.
    Olson, Kristin A.
    ACADEMIC PATHOLOGY, 2020, 7
  • [46] Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma
    Roh, Jin
    Yoon, Dok Hyun
    Lee, Yoon Kyoung
    Pak, Hyo-Kyung
    Kim, Sang-Yeob
    Han, Jae Ho
    Park, Joon Seong
    Jeong, Seong Hyun
    Choi, Yoon Seok
    Cho, Hyungwoo
    Suh, Cheolwon
    Huh, Jooryung
    Lee, Dae Ho
    Park, Chan-Sik
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (03) : 289 - 299
  • [47] Spinal lesion as the first manifestation of high-grade B-cell lymphoma, with MYC and BCL2 rearrangements
    Ye, Yunxia
    Zhang, Wenyan
    Zhao, Sha
    Jiang, Lili
    Liu, Weiping
    Long, Yanhong
    Wan, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8858 - 8862
  • [48] Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene
    Lima, Francisco Pignataro
    Bousquet, Marina
    Gomez-Brouchet, Anne
    de Paiva, Geisilene Russano
    Amstalden, Eliane Maria Ingrid
    Soares, Fernando Augusto
    Dastugue, Nicole
    Vassallo, Jose
    Brousset, Pierre
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (05) : 723 - 726
  • [49] Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements Clinicopathologic Features of 11 Cases
    Wang, Wei
    Hu, Shimin
    Lu, Xinyan
    Young, Ken H.
    Medeiros, L. Jeffrey
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1132 - 1139
  • [50] Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy
    Takahashi, Hiromichi
    Miura, Katsuhiro
    Nakagawa, Masaru
    Sugitani, Masahiko
    Amano, Yusuke
    Kurita, Daisuke
    Sakagami, Masashi
    Ohtake, Shimon
    Uchino, Yoshihito
    Kodaira, Hitomi
    Iriyama, Noriyoshi
    Kobayashi, Sumiko
    Hojo, Atsuko
    Kobayashi, Yujin
    Hirabayashi, Yukio
    Kusuda, Machiko
    Hatta, Yoshihiro
    Nakayama, Tomohiro
    Takei, Masami
    LEUKEMIA & LYMPHOMA, 2016, 57 (12) : 2784 - 2790